Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07757113
Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolizationphenox Inc.Not Yet RecruitingNot Applicable
NCT07757113Not Yet Recruiting
Not Applicable
Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergo...phenox Inc.
NCT07758491
A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell LymphomaFutureGen Biopharmaceutical (Beijing) Co., LtdNot Yet RecruitingPhase 1
NCT07758491Not Yet Recruiting
Phase 1
A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Ly...FutureGen Biopharmaceutic...
NCT07757802
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy AdultsNational Institute of Allergy and Infectious Diseases (NIAID)Not Yet RecruitingPhase 1
NCT07757802Not Yet Recruiting
Phase 1
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Ad...National Institute of All...
NCT07759037
Fluorescent Hand Hygiene Training and Long-Term Effects in First-Year Nursing StudentsPowiślańska Academy of Applied SciencesNot Yet RecruitingNot Applicable
NCT07759037Not Yet Recruiting
Not Applicable
Fluorescent Hand Hygiene Training and Long-Term Effects in First-Year Nursing St...Powiślańska Academy of Ap...
NCT07758621
SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCCCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 3
NCT07758621Not Yet Recruiting
Phase 3
SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Me...CSPC Megalith Biopharmace...
NCT07758933
Safety of Lactobacillus LB Postbiotic in Immunocompromised Paediatric Patients With Diarrhoeal DiseaseAequitas MedicaNot Yet RecruitingPhase 1
NCT07758933Not Yet Recruiting
Phase 1
Safety of Lactobacillus LB Postbiotic in Immunocompromised Paediatric Patients W...Aequitas Medica
NCT07757204
An Open-label Long-term Safety Study of Buntanetap in Participants With ADAnnovis Bio Inc.Not Yet RecruitingPhase 2
NCT07757204Not Yet Recruiting
Phase 2
An Open-label Long-term Safety Study of Buntanetap in Participants With ADAnnovis Bio Inc.
NCT07758751
Multisensory 40-Hz Stimulation for Alzheimer's DiseaseBeijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07758751Not Yet Recruiting
Not Applicable
Multisensory 40-Hz Stimulation for Alzheimer's DiseaseBeijing Tiantan Hospital
NCT07757594
FARES Versus Traction-Countertraction for Acute Anterior Shoulder DislocationNgoc Quyen LeNot Yet RecruitingNot Applicable
NCT07757594Not Yet Recruiting
Not Applicable
FARES Versus Traction-Countertraction for Acute Anterior Shoulder DislocationNgoc Quyen Le
NCT07756801
CAPITAL OFFLOAD-SHOCKOttawa Heart Institute Research CorporationNot Yet RecruitingPhase 4
NCT07758816
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Research CollaborationRecruiting
NCT07758816Recruiting
—
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Rese...
NCT07758283
Intergenerational Risk and Resilience of Rohingya in DisplacementInternational Centre for Diarrhoeal Disease Research, BangladeshActive Not Recruiting
NCT07758283Active Not Recruiting
—
Intergenerational Risk and Resilience of Rohingya in DisplacementInternational Centre for...
NCT07757815
Multimodal Biomarkers and Precision TMS for Postpartum DepressionKiang Wu HospitalNot Yet RecruitingNot Applicable
NCT07757815Not Yet Recruiting
Not Applicable
Multimodal Biomarkers and Precision TMS for Postpartum DepressionKiang Wu Hospital
NCT07758556
Comparison of Alignment Speed, Patient Discomfort and Root Resorption Between Two Different Sequences of ArchwiresFoundation University IslamabadCompletedNot Applicable
NCT07758556Completed
Not Applicable
Comparison of Alignment Speed, Patient Discomfort and Root Resorption Between Tw...Foundation University Isl...
NCT07758335
The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative Colitis Patients the Patient Will be Recruited From Outpatient Clinic of IBD and Gastroenterology of the National Hepatology and Tropical Medicine Research Institute (NHTMRI), Cairo, Egypt.National Hepatology & Tropical Medicine Research InstituteRecruitingPhase 4
NCT07758335Recruiting
Phase 4
The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of...National Hepatology & Tro...
NCT07758998
The Effect of Motivational Interviewing on Smoking Behavior Among Nursing StudentsMeral Feratoğlu ResearchNot Yet RecruitingNot Applicable
NCT07758998Not Yet Recruiting
Not Applicable
The Effect of Motivational Interviewing on Smoking Behavior Among Nursing Studen...Meral Feratoğlu Research
NCT07758985
Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali.London School of Hygiene and Tropical MedicineNot Yet RecruitingPhase 1
NCT07758985Not Yet Recruiting
Phase 1
Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner...London School of Hygiene...
NCT07757230
A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast CancerShenyang Sunshine Pharmaceutical Co., LTD.Not Yet RecruitingPhase 2
NCT07757230Not Yet Recruiting
Phase 2
A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low o...Shenyang Sunshine Pharmac...
NCT07758127
Updates and Insights on HER2 in Breast Cancer in Sohag GovernorateSohag Oncology CenterNot Yet Recruiting
NCT07758127Not Yet Recruiting
—
Updates and Insights on HER2 in Breast Cancer in Sohag GovernorateSohag Oncology Center
NCT07757048
A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patients in the United StatesNovartis PharmaceuticalsCompleted
NCT07757048Completed
—
A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patient...Novartis Pharmaceuticals
Result Breakdown
Not yet recruiting15 (75%)
Recruiting2 (10%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable7 (35%)
Phase 14 (20%)
Not Specified4 (20%)
Phase 22 (10%)
Phase 42 (10%)
Phase 31 (5%)